MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Xiao-Pin MaDe-Ke Jiang

Abstract

Single nucleotide polymorphisms (SNPs) within microRNAs (miRNAs) are considered potential markers for risk and prognosis of various cancers. In the current study, we aimed to determine whether miR-608 rs4919510 affected hepatocellular carcinoma (HCC) prognosis. We genotyped rs4919510 using DNA from blood samples of 362 HCC patients receiving surgical resection of HCC tumor. Associations between rs4919510 and overall survival (OS) and demographic characteristics and clinical features were estimated using the Cox proportional hazards model. Results showed that HCC patients who carried the rs4919510 CC genotype had a significantly longer OS compared to those who carried the GG genotype (P = 0.013, hazard ratio [HR] = 0.600, 95 % confidence interval [CI] 0.402-0.897) and the CG + GG genotype (P = 0.033, HR = 0.681, 95 % CI 0.479-0.970) in univariate analysis. Similar results were obtained in multivariate analysis. Further stratification analysis indicated that rs4919510 was significantly associated with OS in patients who were satisfied with one of the following criteria: male gender, HbsAg-positive, α-fetoprotein (AFP)-positive, tumor size >5 cm, cirrhosis, solitary tumor, I + II pTNM stage, or no tumor capsule. Finally, a signifi...Continue Reading

References

Sep 17, 2004·The EMBO Journal·Yoontae LeeV Narry Kim
May 27, 2005·Seminars in Liver Disease·Margarita SalaJordi Bruix
Jul 7, 2005·Nature Structural & Molecular Biology·Bonnie Bartel
Oct 25, 2006·Nature Reviews. Cancer·George A Calin, Carlo M Croce
May 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Krystian JazdzewskiAlbert de la Chapelle
Jun 4, 2008·The Journal of Clinical Investigation·Zhibin HuHongbing Shen
May 25, 2010·Nature Reviews. Cancer·Bríd M RyanCurtis C Harris
Jul 16, 2010·Nature Reviews. Gastroenterology & Hepatology·Ju Dong Yang, Lewis R Roberts
Oct 27, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jinliang XingHushan Yang
May 29, 2012·Journal of Cell Science·Zina Jeyapalan Rutnam, Burton B Yang
Jun 2, 2012·The Lancet Oncology·Yi W KongMartin Bushell
Jun 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Moubin LinXifeng Wu
Jun 23, 2012·Translational Gastrointestinal Cancer·Christopher JohnsonFanyin Meng
Oct 2, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yuxin WangGeorge R Stark
Apr 4, 2014·World Journal of Gastroenterology : WJG·Seow Chong LeeMaxey Ching Ming Chung
Apr 26, 2014·Cancer Immunology Research·Toshio Tanaka, Tadamitsu Kishimoto
Sep 10, 2014·Menopause : the Journal of the North American Menopause Society·HyungChul RahNam Keun Kim
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Mar 3, 2015·World Journal of Hepatology·Kerstin SchüttePeter Malfertheiner
Jun 16, 2016·Journal of Biomedical Nanotechnology·Nikhil TyagiAjay P Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.